Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#2878 Surgical Management of Neuroendocrine Tumor-Associated Liver Metastases
Introduction: Liver metastasis is common among patients who suffer from neuroendocrine tumors (NETs). Radical surgery is the standard treatment whenever possible but there is still controversies concerning the treatment strategies such as resection of the primary, role of debulking surgery, liver transplantation (LT) and neoadjuvant or adjuvant therapies.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Bengueddach A, Boudjnene N, Derriche H, Kaid M, Tabeti B,
Keywords: surgery, pancreas, liver metastasis,
Introduction: In advanced NETs antiproliferative treatment options beyond somatostatin analogues remain limited. Temozolomide (TMZ) has shown efficacy in NETs alone or combined with other drugs.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Pavel M, Denecke T, Lahner H, Hörsch D, Rinke A,
Keywords: lanreotide, temozolomide, somatostatin analogues, combination therapy, progressive advanced NET, SONNET,
Introduction: Therapeutic options for patients with advanced progressive GEP-NET are still limited.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Raderer M
Authors: Raderer M, Hörsch D, Lahner H, Rinke A, Denecke T,
Keywords: GEP-NET, Lanreotide, Temozolomide,
#1271 Bone Metastases in NEN Patients - Frequency, Clinical, Therapeutic and Prognostic Relevance
Introduction: Up to 73% of patients with neuroendocrine neoplasms (NEN) present with distant metastases at diagnosis. Advanced stage negatively correlates with prognosis. Bone metastases (BM) are usually reported in less than 10% of patients. Improved imaging results in more frequent detection but information in general is very limited.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author:
Authors: Scharf M, Michel V, Rinke A, Gress T,
Keywords: bone metastases, frequency, relevance,
Introduction: Chemotherapy (CTx) with temozolomid as mono (TEM) or combination therapy with capcitabine (TEM/CAP) is a new cytotoxic regimen with good efficiency in pancreatic and bronchopulmonary NET-G1/G2 and NEC-G3.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author:
Authors: Maasberg S, Bacher M, Rinke A, Lahner H, Unger N,
Keywords: temozolomide, capecitabine,